TL;DR
This paper reveals the atomic structures of galanin bound to its receptors (GAL1R and GAL2R), uncovering a novel "lay flat" binding mode. This structural insight explains how galanin selectively activates different G protein subtypes and identifies intracellular loop 2 (ICL2) as a key determinant for Gq coupling, offering a new framework for designing selective GPCR drugs.
What Problem Does This Paper Address?
G protein-coupled receptors (GPCRs) are crucial drug targets, and understanding how peptide ligands like galanin interact with them is fundamental for drug discovery. Two major unanswered questions in this field were: 1) how peptide ligands achieve diverse binding modes to their receptors, and 2) how these interactions lead to specific G protein coupling. Galanin, a neuropeptide involved in various physiological processes, signals through three receptors (GAL1R, GAL2R, and GAL3R), which couple to different G protein subtypes (GAL1R primarily to Gi, GAL2R to Gq). However, the structural basis for this selective G protein coupling remained elusive. This paper aims to elucidate these mechanisms by providing high-resolution structures of galanin bound to GAL1R and GAL2R in complex with their cognate G proteins.
Methods
The researchers employed cryo-electron microscopy (cryo-EM) to determine the structures of the galanin-receptor-G protein complexes. This technique allows for the visualization of large molecular assemblies at near-atomic resolution. To enhance the stability of these complexes for cryo-EM, they utilized scFv16 for the GAL1R-Gi complex and a NanoBiT tethering strategy for the GAL2R-Gq complex. Following structural determination, they performed extensive mutagenesis studies and functional assays (including saturation binding, competition binding, calcium assays, and cAMP assays) to validate the structural findings and investigate the roles of specific amino acid residues and protein loops in ligand recognition and G protein coupling.
Datasets
Not discussed in the paper. The study primarily relies on experimental data generated through cryo-EM and biochemical assays.
Key Insights and Ideas
- A Novel "Lay Flat" Binding Pose: Galanin doesn't insert deeply into the receptor pocket like many other peptide ligands. Instead, it lies almost horizontally on the extracellular surface, adopting an α-helical conformation. This is a significant departure from previously understood peptide-GPCR interactions.
- ICL2 as a Master Switch for Gq Coupling: The study strongly implicates Intracellular Loop 2 (ICL2) of the receptor as a critical determinant for selective Gq protein coupling. Swapping ICL2 between GAL1R and GAL2R dramatically altered their G protein coupling preferences.
- Allosteric-Like Activation: The unique binding mode and the subsequent propagation of the signal through positively charged residues suggest an "allosteric-like" activation mechanism, where the ligand binding site is distant from the G protein interaction interface.
- Structural Basis for Drug Design: The detailed structural information provides a template for designing more selective galanin receptor agonists or antagonists, potentially leading to improved therapeutics for conditions like chronic pain and mood disorders.
Key Results
- High-resolution cryo-EM structures (2.7 Å for GAL1R-Gi and 2.6 Å for GAL2R-Gq) were obtained, revealing the molecular details of galanin binding and G protein interaction.
- Galanin adopts a unique "lay flat" binding pose, with its N-terminus forming an α-helix on the receptor's extracellular face, and only Tyr9 (Y9) inserting into a shallow pocket.
- Mutagenesis studies confirmed the importance of specific residues in ECL2 and TM6-ECL3-TM7 for galanin binding and activation.
- ICL2 swapping experiments demonstrated that GAL2R's ICL2 is essential for its selective Gq coupling. Replacing GAL1R's ICL2 with GAL2R's ICL2 conferred Gq coupling ability to GAL1R.
- This ICL2-mediated Gq selectivity was further shown to be applicable to other GPCRs, including those that natively couple to Gs and Gi proteins, highlighting ICL2 as a potential universal determinant for Gq coupling.
Limitations and Future Work
- In Vitro System: The study was conducted using engineered cell lines and purified complexes, which may not fully recapitulate the in vivo cellular environment.
- Gq Chimera: While the Gq chimera was validated, its use might introduce subtle differences compared to endogenous Gq.
- Future Work: The authors suggest designing galanin analogs or small molecules that can fill the extra space identified in the galanin binding pocket, potentially leading to novel therapeutic opportunities. Further investigation into the commonality of ICL2 on Gq-coupling preference across a broader range of GPCRs is also suggested. The findings provide a foundation for understanding other peptide-GPCR interactions and designing selective drugs.
Summary updated